drugset / Trial / NCT02136329

A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery

NCT02136329

NaSingle-groupOpen-labelPrevention

Summary

The objectives of the study are the following: * To evaluate the pharmacokinetic profile of Sildenafil in cardiac surgery patients at risk of acute kidney injury * To determine the safety and tolerability of Sildenafil in cardiac surgery patients at risk of acute kidney injury

Timeline

Start
2013-06
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 10 mg Intravenous

Indications